Bolt Biotherapeutics, Inc. (BOLT): Form 8-K filed 2026-10-23

Accepted by EDGAR

2026-10-23 10:31 ET

Event date

2026-10-23

Accession no.

0001193125-26-429647

Original filing

SEC EDGAR filing index

Items reported

• Item 1.01: Entry into a Material Definitive Agreement
  The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
• Item 1.02: Termination of a Material Definitive Agreement
  A material agreement was terminated other than by expiring on its stated date. The company describes the agreement, the circumstances of the termination and any material early-termination penalties.
• Item 2.01: Completion of Acquisition or Disposition of Assets
  The company completed the acquisition or disposition of a significant amount of assets, including a business. The report covers the date, the assets, the counterparty and the consideration.
• Item 3.02: Unregistered Sales of Equity Securities
  The company sold equity securities in a transaction not registered under the Securities Act, such as a private placement, above a size threshold.
• Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
  A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed.
• Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
  The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year.
• Item 7.01: Regulation FD Disclosure
  The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
• Item 8.01: Other Events
  A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
• Item 9.01: Financial Statements and Exhibits
  Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Documents

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.